Country Profile

Hungary

Hungary is a significant market for Indian pharmaceutical exports — $114M in FY 2025–26. Medicines accounts for 84% of shipments, with vaccines contributing $514K.

🇭🇺 $114M · 1.1× growth since FY2015 · 1.1% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$114M
Exports FY2025–26 DGCIS
1.1×
Growth FY2015→2026
1.1%
CAGR FY2015→2026
84%
Medicines Share
5
Product Categories Supplied
Hungary is a significant market for Indian pharmaceutical exports — $114M in FY 2025–26. Medicines accounts for 84% of shipments, with vaccines contributing $514K.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $95.2M (83.6%) Medicine Ingredients $16.8M (14.8%) Surgical & Hospital Supplies $695K (0.6%) Traditional & Herbal $591K (0.5%) Vaccines $514K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Hungary in the RBI overseas direct investment dataset (2011–2026).